Appili Therapeutics Inc stock dipped on Wednesday.
Today in trading, shares of Appili Therapeutics Inc opened at $0.07 and closed at $0.07. It traded at a low of $0.07 to a high of $0.07.
Shares reduced -7.14 percent from the previous day's close of $0.07.
During the day across North America, the TSX Composite closed -0.46% at 19578.30, the S&P 500 closed -0.42% at 4122.47, the Dow Jones Industrial Average closed -0.18% at 32774.41 and the Nasdaq Composite closed -1.19% at 12493.93.
Appili Therapeutics Inc has listed on the TSX stock exchange under the ticker APLI.TO.
A total of 114,658 shares was traded during the last trading day, with total trades of 13. On average, Appili Therapeutics Inc has traded 51,697 shares over 5 days and 178,035 year-to-date.
The TSX overall saw 4,557 price advancers against 1,077 declines and 259 unchanged.
During the prior 52 weeks, APLI.TO has traded as high as $1.14 (September 30,2021) and low as $0.06 (July 22,2022). Moreover, in the last 52 weeks, Appili Therapeutics Inc's shares have plummeted -89.44 percent, while in 2022, they have reduced -34.78%.
Following today's trading, Appili Therapeutics Inc has a market capitalization of $8.49 million on a float of 121,266 shares outstanding. Its annual EPS is $-0.38.
Appili Therapeutics Inc is a None company headquartered in Halifax, US.
Based on 2.00 analysts, Appili Therapeutics Inc gets an average recommendation of "Hold" according to Zacks. From those 2 analysts, 2 analysts gave hold ratings.
Artificial Intelligence at Report on Business
Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..